AKT1 and cancer: Medicarpin has demonstratedsignificant antiproliferative and pro-apoptotic effects in variousin vitro cancer models by targeting key apoptotic and survival pathways.It induces apoptosis through both intrinsic and extrinsic mechanisms,enhances sensitivity to chemotherapeutic agents, and modulates crucialsignaling pathways such as PTEN/AKT, highlighting its potential asa versatile therapeutic agent.